Neofordex (Dexamethasone)

Dexamethasone, the active ingredient in Neofordex, is a corticosteroid presented as an oral tablet for oral use. It reduces inflammation and modulates immune responses, and is prescribed for a range of inflammatory, autoimmune and respiratory conditions in adult and pediatric patients. The drug is commonly employed in the management of allergic reactions, asthma exacerbations, rheumatoid arthritis, certain dermatologic disorders, and as part of therapy for specific cancers, providing rapid symptom control when needed.

GNH USA supplies Neofordex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neofordex (dexamethasone) acts on inflammatory and immune pathways to treat several conditions.

- Inflammatory and autoimmune disorders: reduces inflammation and suppresses immune activity to improve symptoms. - Allergic reactions: diminishes swelling, itching and airway constriction. - Asthma and COPD exacerbations: rapidly decreases airway inflammation for better breathing. - Rheumatoid arthritis: alleviates joint pain, swelling and stiffness. - Dermatologic conditions: controls severe skin inflammation such as eczema or psoriasis. - Certain hematologic and solid‑tumor malignancies: provides anti‑inflammatory and anti‑emetic support as part of cancer therapy.

Dexamethasone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hyperglycemia: elevated blood sugar levels, especially in diabetic patients. - Fluid retention/edema: swelling of ankles, hands or face due to sodium retention. - Insomnia: difficulty falling or staying asleep. - Increased appetite: heightened hunger leading to weight gain.

Serious or Rare Side Effects: - Severe infection: heightened risk of bacterial, viral or fungal infections. - Adrenal suppression: reduced endogenous cortisol production causing fatigue and hypotension. - Osteoporosis: loss of bone density increasing fracture risk.

When prescribing dexamethasone, clinicians should consider several precautionary measures to minimize risks.

- Monitor blood glucose: check glucose levels regularly in patients with diabetes or at risk. - Assess infection risk: evaluate for active infections before initiating therapy. - Evaluate bone health: consider calcium and vitamin D supplementation or bone density monitoring. - Use lowest effective dose: limit exposure to reduce side‑effect potential. - Taper therapy: gradually reduce dose when discontinuing to avoid adrenal crisis. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Dexamethasone can interact with other medicines, altering their effects or increasing toxicity.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase dexamethasone levels. - Live vaccines: risk of reduced vaccine efficacy and infection. - Anticoagulants (warfarin): enhanced anticoagulant effect, increasing bleeding risk. - NSAIDs (e.g., ibuprofen): heightened gastrointestinal ulcer risk.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, phenytoin): may lower dexamethasone concentrations. - Diuretics (e.g., furosemide): can exacerbate potassium loss and fluid imbalance. - Antidiabetic agents (e.g., insulin, oral hypoglycemics): may require dose adjustments due to altered glucose control.